SMTL ID : 3wcj.1 (2 other biounits)

The complex structure of HsSQS wtih ligand,E5700

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

homo-hexamer

Ligands

6 x E5S: (3R)-3-({2-benzyl-6-[(3R,4S)-3-hydroxy-4-methoxypyrrolidin-1-yl]pyridin-3-yl}ethynyl)-1-azabicyclo[2.2.2]octan-3-ol(Non-covalent)

E5S.1: 16 residues within 4Å: Chain A: F.44, I.48, V.59, Y.63, L.66, D.70, V.165, A.166, V.169, L.173, M.197, L.201, Y.266, F.278, C.279, Q.283 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:I.48, A:V.59, A:Y.63, A:L.66, A:D.70, A:V.169, A:L.173, A:L.201, A:F.278 Hydrogen bonds: A:C.279, A:Q.283 Salt bridges: A:D.70 pi-Stacking: A:F.44, A:Y.63 E5S.2: 18 residues within 4Å: Chain B: F.44, I.48, V.59, Y.63, L.66, D.70, V.165, A.166, V.169, L.173, M.197, L.201, Q.202, Y.266, F.278, C.279, P.282, Q.283 14 PLIP interactions: 14 interactions with chain B Hydrophobic interactions: B:I.48, B:V.59, B:Y.63, B:D.70, B:V.169, B:V.169, B:V.169, B:L.173, B:L.201, B:F.278 Hydrogen bonds: B:Q.283 Salt bridges: B:D.70 pi-Stacking: B:F.44, B:Y.63 E5S.3: 17 residues within 4Å: Chain C: F.44, I.48, V.59, Y.63, L.66, D.70, V.165, A.166, V.169, G.170, L.173, M.197, L.201, Y.266, F.278, C.279, Q.283 15 PLIP interactions: 15 interactions with chain C Hydrophobic interactions: C:F.44, C:I.48, C:V.59, C:Y.63, C:Y.63, C:D.70, C:V.169, C:L.173, C:L.201, C:F.278 Hydrogen bonds: C:C.279, C:Q.283 Salt bridges: C:D.70 pi-Stacking: C:F.44, C:Y.63 E5S.4: 17 residues within 4Å: Chain D: F.44, I.48, V.59, Y.63, L.66, D.70, V.165, A.166, V.169, G.170, L.173, M.197, L.201, Y.266, F.278, C.279, Q.283 14 PLIP interactions: 14 interactions with chain D Hydrophobic interactions: D:F.44, D:I.48, D:V.59, D:Y.63, D:D.70, D:V.169, D:V.169, D:L.201, D:F.278 Hydrogen bonds: D:C.279, D:Q.283 Salt bridges: D:D.70 pi-Stacking: D:F.44, D:Y.63 E5S.5: 18 residues within 4Å: Chain E: F.44, I.48, V.59, Y.63, R.67, D.70, V.165, A.166, V.169, L.173, M.197, G.198, L.201, Q.202, Y.266, F.278, C.279, Q.283 17 PLIP interactions: 17 interactions with chain E Hydrophobic interactions: E:F.44, E:I.48, E:V.59, E:Y.63, E:D.70, E:V.169, E:V.169, E:V.169, E:V.169, E:L.173, E:L.201, E:F.278 Hydrogen bonds: E:C.279, E:Q.283 Salt bridges: E:D.70 pi-Stacking: E:F.44, E:Y.63 E5S.6: 19 residues within 4Å: Chain F: F.44, I.48, V.59, F.62, Y.63, L.66, D.70, V.165, A.166, V.169, L.173, M.197, L.201, Q.202, Y.266, F.278, C.279, P.282, Q.283 18 PLIP interactions: 18 interactions with chain F Hydrophobic interactions: F:F.44, F:I.48, F:V.59, F:F.62, F:Y.63, F:L.66, F:D.70, F:V.169, F:V.169, F:V.169, F:V.169, F:L.173, F:L.201, F:F.278 Hydrogen bonds: F:C.279, F:Q.283 Salt bridges: F:D.70 pi-Stacking: F:Y.63

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Shang, N. et al., Squalene synthase as a target for Chagas disease therapeutics. Plos Pathog. (2014)

Release Date

2014-06-18

Peptides

Squalene synthase: ABCDEF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

E
E

F
F

Squalene synthase

Related Entries With Identical Sequence